Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.
Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer. BMC Cancer. 2016 08 02; 16:568.